查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1666158

全球微波消融設備市場 - 2025 年至 2033 年

Global Microwave Ablation Devices Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 210 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球微波消融設備市場規模達到 3.7816 億美元，預計到 2033 年將達到 11.4574 億美元，2025-2033 年預測期內的複合年成長率為 13.0%。

微波消融設備是利用微波能量破壞異常組織（如腫瘤或有害生長物）的醫療儀器。它們發射高頻電磁波，引起組織中的水分子振動並產生熱量，導致凝固性壞死。它們廣泛用於腫瘤學治療肝臟、肺臟、腎臟、骨腫瘤、心血管、泌尿和婦科疾病。與其他熱消融技術相比，微波消融具有更深的組織穿透力、更高的溫度和更快的治療時間。

市場動態：

促進因素與約束因素

癌症和其他慢性疾病發生率不斷上升

微波消融設備市場的發展受到癌症和其他需要微創治療的慢性疾病發生率上升的推動。由於全球肝臟、肺臟和腎臟腫瘤的負擔，與傳統手術方法相比，微波消融具有手術時間更快、組織破壞效率更高、併發症更少等特徵。醫院和門診手術中心採用影像導引消融技術也推動了市場成長。

例如，根據美國癌症協會根據中央癌症登記處和國家衛生統計中心的資料預測，到 2024 年，美國將出現 2,001,140 例新癌症病例和 611,720 例死亡病例。

嚴格的法規核准

由於 FDA 和 EMA 嚴格的法規核准和合規要求，微波消融設備市場面臨重大挑戰。這些指南確保設備在進入市場之前的安全性和有效性。核准過程非常耗時，需要大量的臨床試驗、文件和品質控制措施。這可能會延遲產品發布、增加成本和複雜性，這可能會限制市場成長。

目錄

第 1 章：方法與範圍

第 2 章：定義與概述

第 3 章：執行摘要

第 4 章：動態

  • 影響因素
    • 驅動程式
      • 癌症和其他慢性疾病發生率不斷上升
    • 限制
      • 嚴格的法規核准
    • 機會
    • 影響分析

第5章：戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的成熟領導者
    • 擁有成熟產品的市場領導者
  • CXO 觀點
  • 最新進展與突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT 分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態
  • 關鍵意見領袖

第 6 章：按組件類型

  • 發電機
  • 配電系統
  • 配件

第 7 章：按應用

  • 腫瘤學
  • 心血管
  • 泌尿科
  • 骨科
  • 其他

第 8 章：按最終用戶

  • 醫院
  • 門診手術中心
  • 診所

第9章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 10 章：競爭格局

  • 競爭格局
  • 市場定位/佔有率分析
  • 併購分析

第 11 章：公司簡介

  • AngioDynamics
    • 公司概況
    • 產品組合
      • 產品描述
      • 產品關鍵績效指標 (KPI)
      • 歷史和預測產品銷售量
      • 產品銷售量
    • 財務概覽
      • 公司收入
      • 地區收入佔有率
      • 收入預測
    • 主要進展
      • 合併與收購
      • 關鍵產品開發活動
      • 監管部門批准等
    • SWOT 分析
  • Medtronic Plc
  • Boston Scientific Corporation
  • Johnson & Johnson Inc
  • Emblation
  • MedWaves, Inc
  • Symple Surgical
  • Urologix, LLC
  • Varian Medical Systems Inc
  • Huber Suhner
  • Similar data will be provided for each market player.
  • 米拉瑪實驗室有限公司
    • 管道產品描述
    • 產品關鍵績效指標 (KPI)
    • 主要活動
    • 市場進入時間表
    • 產品滲透率
    • 銷售估計和預測
  • 簡單外科手術
  • 將為每個市場參與者提供類似的資料。

第 12 章：附錄

簡介目錄
Product Code: MD9150

The Global Microwave Ablation Devices Market reached US$ 378.16 million in 2024 and is expected to reach US$ 1145.74 million by 2033, growing at a CAGR of 13.0% during the forecast period 2025-2033.

Microwave ablation devices are medical instruments that use microwave energy to destroy abnormal tissues, such as tumors or unwanted growths. They emit high-frequency electromagnetic waves, causing water molecules in tissues to vibrate and produce heat, leading to coagulative necrosis. They are widely used in oncology for treating liver, lung, kidney, bone tumors, cardiovascular, urological, and gynecological procedures. Compared to other thermal ablation techniques, microwave ablation offers deeper tissue penetration, higher temperatures, and faster treatment times.

Market Dynamics: Drivers & Restraints

Increasing Prevalence of Cancer and Other Chronic Diseases

The microwave ablation devices market is driven by the rising prevalence of cancer and other chronic diseases requiring minimally invasive treatments. With the global burden of liver, lung, and kidney tumors, microwave ablation offers faster procedure times, higher tissue destruction efficiency, and reduced complications compared to traditional surgical methods. The adoption of image-guided ablation techniques in hospitals and ambulatory surgical centers is also driving market growth.

For instance, according to American Cancer Society predicts in 2024, the US experienced 2,001,140 new cancer cases and 611,720 deaths, based on data from central cancer registries and the National Center for Health Statistics.

Stringent Regulatory Approvals

The microwave ablation devices market faces significant challenges due to stringent regulatory approvals and compliance requirements from the FDA and EMA. These guidelines ensure safety and efficacy of devices before they reach the market. The approval process is time-consuming and requires extensive clinical trials, documentation, and quality control measures. This can delay product launches, increase costs, and complexity, potentially limiting market growth.

Segment Analysis

The global Microwave Ablation Devices market is segmented based on Component Type, Application, End User and Region.

Component Type:

Generator segment is expected to dominate the Microwave Ablation Devices market share

The generator segment holds a major portion of the microwave ablation devices market share and is expected to continue to hold a significant portion of the microwave ablation devices market share during the forecast period.

Microwave ablation devices rely on generators for energy generation, controlling the frequency, power output, and duration of microwave emissions. Advancements in generator technology, including improved energy efficiency, real-time monitoring, and integration with imaging systems, enhance the accuracy and safety of ablation procedures. The growing demand for generators with higher power output and better thermal control drives market innovations, contributing to the expansion of microwave ablation therapies.

End User:-

Hospitals segment is the fastest-growing segment in Microwave Ablation Devices market share

The hospitals segment is the fastest-growing segment in the Microwave Ablation Devices market share and is expected to hold the market share over the forecast period.

Hospitals are leading the market in microwave ablation devices due to their primary role in healthcare. With increasing cases of cancer and chronic diseases requiring ablation therapy, hospitals invest in advanced systems for minimally invasive treatment. Specialized oncology and radiology departments enable the integration of microwave ablation with imaging technologies like CT and ultrasound. Government funding, reimbursement policies, and skilled healthcare professionals support the widespread use of microwave ablation devices in clinical practice.

For instance, in January 2025, Sringeri Sharada Equitas (SSE) hospital in Chennai has introduced Microwave Ablation treatment for affordable cancer treatment and curing, using microwave energy to kill and shrink tumor cells in organs like kidney, lungs, and liver.

Geographical Analysis

North America is expected to hold a significant position in the Microwave Ablation Devices market share

North America holds a substantial position in the Microwave Ablation Devices market and is expected to hold most of the market share due to advanced healthcare infrastructure, minimally invasive procedures, and investment in medical technology innovation. Key players like Medtronic and Boston Scientific develop cutting-edge ablation technologies. The rising prevalence of cancer, particularly liver and lung cancer, and government initiatives for treatment also increase demand for microwave ablation procedures. Favorable reimbursement policies and skilled healthcare professionals further contribute to market expansion.

For instance, in July 2024, Siemens Healthineers' Varian has received FDA clearance for its IntelliBlate microwave ablation system, designed for soft tissue ablation. The system offers clinicians greater predictability, precision, and control, forming the foundation of a future-focused, integrated microwave ablation ecosystem.

Europe is growing at the fastest pace in the Microwave Ablation Devices market

Europe holds the fastest pace in the Microwave Ablation Devices market and is expected to hold most of the market share is driven by rising healthcare expenditure, increased awareness of minimally invasive cancer treatments, and advancements in imaging technology. Countries like Germany, France, and the UK are leading due to strong research and development, rising cancer cases, well-regulated healthcare policies, and funding for cancer treatment programs. The expansion of ambulatory surgical centers and preference for outpatient procedures also contribute to market growth.

For instance, in March 2024, Creo Medical Group has made significant progress in the field of minimally invasive surgical endoscopy for pre-cancer and cancer patients. Professor Pallav Shah and Dr Christopher Orton at the Royal Brompton Hospital have become the first specialists to perform a robotic guided microwave ablation of lung tissue in the same sitting as a diagnostic procedure. The procedure, which took three minutes, involved the ablation of a 27mm cancerous nodule in a patient's lung.

Competitive Landscape

The major global players in the Microwave Ablation Devices market include AngioDynamics, Medtronic Plc, Boston Scientific Corporation, Johnson & Johnson Inc, Emblation, MedWaves, Inc, Symple Surgical, Urologix, LLC, Varian Medical Systems Inc, Huber Suhner and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global Microwave Ablation Devices market report delivers a detailed analysis with 61 key tables, more than 59 visually impactful figures, and 210 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Component Type & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Component Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Prevalence of Cancer and Other Chronic Diseases
    • 4.1.2. Restraints
      • 4.1.2.1. Stringent Regulatory Approvals
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Strategic Insights and Industry Outlook

  • 5.1. Market Leaders and Pioneers
    • 5.1.1. Emerging Pioneers and Prominent Players
    • 5.1.2. Established leaders with largest selling Brand
    • 5.1.3. Market leaders with established Product
  • 5.2. CXO Perspectives
  • 5.3. Latest Developments and Breakthroughs
  • 5.4. Case Studies/Ongoing Research
  • 5.5. Regulatory and Reimbursement Landscape
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa
  • 5.6. Porter's Five Force Analysis
  • 5.7. Supply Chain Analysis
  • 5.8. Patent Analysis
  • 5.9. SWOT Analysis
  • 5.10. Unmet Needs and Gaps
  • 5.11. Recommended Strategies for Market Entry and Expansion
  • 5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.13. Pricing Analysis and Price Dynamics
  • 5.14. Key Opinion Leaders

6. By Component Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
    • 6.1.2. Market Attractiveness Index, By Component Type
  • 6.2. Generator*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Power Distribution System
  • 6.4. Accessories

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Oncology*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Cardiovascular
  • 7.4. Urology
  • 7.5. Orthopedic
  • 7.6. Others

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Ambulatory Surgical Centers
  • 8.4. Clinics

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Spain
      • 9.3.6.5. Italy
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. South Korea
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

Key Market Players

  • 11.1. AngioDynamics*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals etc.
    • 11.1.5. SWOT Analysis
  • 11.2. Medtronic Plc
  • 11.3. Boston Scientific Corporation
  • 11.4. Johnson & Johnson Inc
  • 11.5. Emblation
  • 11.6. MedWaves, Inc
  • 11.7. Symple Surgical
  • 11.8. Urologix, LLC
  • 11.9. Varian Medical Systems Inc
  • 11.10. Huber Suhner
  • Similar data will be provided for each market player.

Emerging Market Players

  • 11.11. Miramar Labs, Inc*
    • 11.11.1. Pipeline Products Description
    • 11.11.2. Product Key Performance Indicators (KPIs)
    • 11.11.3. Key Activities
    • 11.11.4. Market Entry Timelines
    • 11.11.5. Product Penetration Rate
    • 11.11.6. Sales Estimation and Projections
  • 11.12. Symple Surgical
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1 About Us and Services
  • 12.2 Contact Us